Historie von Umsatz, Gewinn und Cashflow aus den offiziellen Geschäftsberichten.
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
Interaktive Charts und vollständige Abschlüsse ansehen → Bewertungsmodell (DCF) →
| Gewinn- und Verlustrechnung | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gesamtumsatz | $3.5B | $3.4B | $3.4B | $3.0B | $2.5B | $2.4B | $2.0B | $2.1B | $1.9B | $1.8B | $1.6B | $1.6B | $1.8B | $1.8B | $1.8B | $1.7B | $1.3B | $1.1B | $1.1B | $548M | $436M |
| Bruttoergebnis | $1.6B | $1.6B | $1.6B | $1.5B | $1.3B | $1.2B | $940M | $995M | $900M | $813M | $742M | $709M | $763M | $805M | $831M | $752M | $606M | $519M | $505M | $253M | $199M |
| Bruttomarge % | 46.7% | 45.9% | 49.0% | 51.0% | 51.6% | 50.0% | 47.3% | 48.0% | 47.5% | 46.0% | 46.1% | 43.6% | 42.2% | 43.8% | 46.4% | 45.6% | 46.4% | 46.5% | 45.6% | 46.2% | 45.7% |
| Betriebsergebnis (EBIT) | $275M | $236M | $253M | $437M | $433M | $413M | $248M | $301M | $262M | $215M | $177M | $146M | $105M | $148M | $156M | $156M | $156M | $137M | $108M | $50M | $31M |
| Operative Marge % | 7.9% | 6.9% | 7.5% | 14.7% | 17.1% | 17.1% | 12.5% | 14.5% | 13.8% | 12.2% | 11.0% | 9.0% | 5.8% | 8.1% | 8.7% | 9.4% | 11.9% | 12.3% | 9.8% | 9.1% | 7.0% |
| Jahresüberschuss | ($72M) | ($9M) | $113M | $427M | $297M | $277M | $158M | $197M | $180M | $79M | $154M | $102M | $57M | $80M | $78M | $92M | $95M | $81M | $65M | $32M | $18M |
| Nettomarge % | -2.1% | -0.2% | 3.4% | 14.4% | 11.7% | 11.5% | 7.9% | 9.5% | 9.5% | 4.5% | 9.5% | 6.3% | 3.1% | 4.3% | 4.3% | 5.6% | 7.3% | 7.3% | 5.9% | 5.8% | 4.2% |
| EBITDA | — | $303M | $439M | $676M | $519M | $497M | $321M | $372M | $340M | $300M | $262M | $229M | $216M | $239M | $212M | $206M | $156M | $166M | $135M | $63M | $50M |
| Ergebnis je Aktie (EPS) | — | $-0.06 | $0.76 | $2.90 | $1.99 | $1.81 | $1.02 | $1.26 | $1.14 | $0.49 | $0.95 | $0.60 | $0.33 | $0.48 | $0.46 | $0.55 | $0.58 | $0.49 | $0.39 | $0.19 | $0.18 |
| Ausstehende Aktien (Mio.) | — | 152M | 150M | 147M | 149M | 153M | 155M | 157M | 157M | 159M | 162M | 169M | 170M | 168M | 167M | 167M | 166M | 165M | 166M | 164M | 103M |
Quelle: veröffentlichte Unternehmensberichte (SEC). Bitte prüfen Sie die Zahlen vor Verwendung auf SEC EDGAR.
Bilanzen, Cashflow-Rechnungen, Quartalsdaten und alle Kennzahlen finden Sie im interaktiven Viewer für BRKR. /companies/us/BRKR
Die Informationen auf dieser Website dienen ausschließlich Bildungs- und Informationszwecken und stellen keine Anlageberatung dar. Es werden keine Kursziele und keine Anlageurteile veröffentlicht.
About TickerBase · Data methodology & sources · Privacy · Terms